| 9618515 |
Assay to capture and detect circulating multiple myeloma cells from blood |
Mark Carle Connelly, Galla Chandra Rao, Marielena Mata, Carrie Morano |
2017-04-11 |
| 8329422 |
Analysis of circulating tumor cells, fragments, and debris |
Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon W. M. M. Terstappen +1 more |
2012-12-11 |
| 7863012 |
Analysis of circulating tumor cells, fragments, and debris |
Galla Chandra Rao, Christopher Larson, Madeline Repollet, Herman Rutner, Leon W. M. M. Terstappen +1 more |
2011-01-04 |
| 6967219 |
Reversing or preventing premature vascular senescence |
Michael Goligorsky |
2005-11-22 |
| 6784178 |
Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity |
Caroline Jones |
2004-08-31 |
| 6274581 |
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
— |
2001-08-14 |
| 6231894 |
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
Jonathan S. Stamler, Brian J. Day, Owen W. Griffith |
2001-05-15 |
| 6153615 |
Blocking induction of tetrahydrobioterin to block induction of nitric oxide synthesis |
— |
2000-11-28 |
| 5880124 |
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
— |
1999-03-09 |
| 5877176 |
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
— |
1999-03-02 |
| 5874433 |
Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
— |
1999-02-23 |
| 5776979 |
Method of use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
Robert G. Kilbourn, Owen W. Griffith |
1998-07-07 |
| 5770623 |
Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
Robert G. Kilbourn, Roberto Levi, Owen W. Griffith |
1998-06-23 |
| 5723448 |
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction |
Owen W. Griffith |
1998-03-03 |
| 5646001 |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof |
Leon W. M. M. Terstappen, Galla Candra Rao, Dhanesh Gohel, Brian P. Feeley, Ellen S. Church +1 more |
1997-07-08 |
| 5545625 |
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction |
Owen W. Griffith |
1996-08-13 |
| 5534545 |
Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production |
Robert G. Kilbourn, Owen W. Griffith |
1996-07-09 |
| 5502050 |
Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
— |
1996-03-26 |
| 5395612 |
Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an .alpha..sub.1 adrenergic agonist |
Owen W. Griffith, Roberto Levi |
1995-03-07 |
| 5374651 |
Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives |
Robert G. Kilbourn, Owen W. Griffith |
1994-12-20 |
| 5334380 |
Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension |
Robert G. Kilbourn, Owen W. Griffith |
1994-08-02 |
| 5312835 |
Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
Robert G. Kilbourn, Owen W. Griffith |
1994-05-17 |
| 5286739 |
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
Robert G. Kilbourn, Owen W. Griffith |
1994-02-15 |
| 5216025 |
Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
Robert G. Kilbourn, Roberto Levi |
1993-06-01 |
| 5028627 |
Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
Robert G. Kilbourn, Roberto Levi, Owen W. Griffith |
1991-07-02 |
